Organisation paid for research Program year 2023 Source: CMS Open Payments

Brigham and Womens Physician Group

Neither a doctor nor a teaching hospital

Research payments

$42,920

20 payments

Through program year 2023, Brigham and Womens Physician Group is reported as receiving $42,920 in research payments, across 20 payments.

By program year

5 rows
Year Kind Amount Payments
2023 Research $1,060 1
2022 Research $1,240 2
2021 Research $12,460 4
2020 Research $27,720 11
2019 Research $440 2

Breakdown

Who paid Research payments · program years 2019–2023
  1. GlaxoSmithKline, LLC. $42,480 18 payments
  2. Novartis Pharmaceuticals Corporation $440 2 payments
Studies the money was for Research payments · program years 2019–2023
  1. A Phase 1 Dose Escalation and Cohort Expansion Study of Tsr-042, An An $31,720 15 payments
  2. A Phase 3, Randomized, Double-Blind, Multicenter Study of Dostarlimab $10,760 3 payments
  3. A Phase I Open Label Multi Center Dose Escalation Study of Oral Bgj398 A Pan FGF R Kinase Inhibitor in Adult Patients With Advanced Solid Malignancies $440 2 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.

Provenance

Source: CMS Open Payments · through program year 2023

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record